U.S. food and drug administration Tagged Articles
Gardasil marketing: putting the profit cart before the proof horse?
On first glance, a study published by drug manufacturer Merck & Co., in the New England Journal of Medicine appears to declare the Gardasil vaccine a resounding success. The pharmaceutical giant points to numbers that show its cervical cancer vaccine
Vaccine watchdog group asks FDA to review Gardasil for possible contamination
A consumer watchdog group that specifically focuses on vaccine safety, SANE Vax, Inc., sent a certified letter to U.S. Food & Drug Administration (FDA) Commissioner Dr. Margaret Hamburg on Sept. 6, asking the agency to review the possibility of contamination
Aggressive marketing of Gardasil plays on public fear of cancer
A recent lecture presented by Southern Methodist University’s Cary M. Maguire Center for Ethics and Public Responsibility, in collaboration with SMU’s Department of Anthropology, examined the ethical questions of pharmaceutical company Merck’s marketing of its Gardasil vaccine. The drug, fast-tracked
FDA approves Gardasil for use in preventing anal cancer
The U.S. Food and Drug Administration (FDA) has approved the use of the Gardasil vaccine for the prevention of anal cancer. Previously, the drug was approved only for use in girls and young women, for the prevention of cervical cancer.
Cervical cancer expert discusses report questioning Gardasil safety
Recently, WTVR CBS-6 News in Richmond, Virginia, brought viewers a troubling report of serious adverse events and 16 deaths linked to the Gardasil vaccine. The vaccine, which is intended to prevent four types of human papillomavirus (HPV) that cause cervical
FDA records raise new concerns about Gardasil safety
Parents in Virginia are worried following the release of a new report that links the Gardasil vaccine to 16 deaths and nearly 4,000 adverse events. Currently, the vaccine, which protects against four types of human papillomavirus (HPV) linked to cervical
Former CDC director to head Merck’s vaccine division, Gardasil
Merck and Co. announced yesterday that Dr. Julie Gerberding, the former director of the U.S. Centers for Disease Control and Prevention, will head the pharmaceutical giant’s vaccine division. Dr. Gerberding served as the CDC director from 2002 to 2009, stepping
